Transitioning to ANSYS

Before joining PADT last July, I have worked on FEA and CFD analyses but my exposure to ANSYS was limited and I was concerned about the transition. To my delight, the software was very easy to learn; most often than not intuitive and self-explanatory (e.g. mechanical wizard), the setup time was minimized after learning couple simple features (e.g. named selection, object generator etc.) and the resources on the ANSYS portal were very instrumental in the learning process. Furthermore, the colleagues at PADT proved to be very knowledgeable and experienced and more importantly responsive and eager to jump for help.

One of the most attractive features that caught my attention was the streamline of the Multiphysics nature that ANSYS has. I have been satisfied with the performance of standalone CFD packages in the past, and same goes for structural ones. But never have I dealt with an extensive software that maintained the quality of a specialized one. The importance of this attribute is showing more and more its powers in recent years given the development of new convoluted products of Multiphysics nature e.g. medical applications.

Using ANSYS to simulate medical applications is one of the most rewarding experience I personally enjoy. Even though, it is definitely satisfying to be able to help accelerate innovation in the aerospace, automotive, and a myriad of other industrial areas…the experience in the medical area has a more refreshing taste, probably due to the clear and direct link to human lives. From intravascular procedures to shoulder implants and microdevices, there is one common factor: ANSYS is decreasing the risks of catastrophic failures, improving the product capabilities and shortening the innovation cycle.

Editors Note: Ziad is part of PADT’s team in Southern California.   He is a graduate of USC and has worked at Boeing, Meggit, and Pacific Consolidated Industries before joining PADT.  He works with the rest of our ANSYS technical staff to make sure our users are getting the most from their ANSYS investment.